Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, UnitedHealth Group's average EBITDA Per Share Growth Rate was -25.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -8.90% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 0.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 9.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of UnitedHealth Group was 406.60% per year. The lowest was -58.60% per year. And the median was 14.25% per year.
UnitedHealth Group (XSWX:UNH) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
UnitedHealth Group 3-Year EBITDA Growth Rate Related Terms
XSWX:UNH vs CVS, ELV, CI: 3-Year EBITDA Growth Rate Comparison
For the Healthcare Plans subindustry, UnitedHealth Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UnitedHealth Group 3-Year EBITDA Growth Rate vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, UnitedHealth Group's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where UnitedHealth Group's 3-Year EBITDA Growth Rate falls into.
UnitedHealth Group 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -8.90% mean?
UnitedHealth Group (XSWX:UNH) has a 3-Year EBITDA Growth Rate of -8.90% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for UnitedHealth Group and its competitors. According to the industry distribution chart, UnitedHealth Group ranks #12 out of 16 companies in the Healthcare Plans industry, placing it in the top 75%.
Is UnitedHealth Group's 3-Year EBITDA Growth Rate too high?
UnitedHealth Group's current 3-Year EBITDA Growth Rate is -8.90%. Based on the distribution chart, UnitedHealth Group ranks #12 out of 16 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, UnitedHealth Group has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does UnitedHealth Group's 3-Year EBITDA Growth Rate compare to CVS and ELV?
According to the Healthcare Plans industry distribution chart, UnitedHealth Group ranks #12 out of 16 companies for 3-Year EBITDA Growth Rate. This places UnitedHealth Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Plans company?
A good 3-Year EBITDA Growth Rate depends on the Healthcare Plans industry context. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for UnitedHealth Group and its competitors. UnitedHealth Group's current 3-Year EBITDA Growth Rate is -8.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnitedHealth Group stock overvalued right now?
UnitedHealth Group (XSWX:UNH) has a current 3-Year EBITDA Growth Rate of -8.90%. The stock's GF Value™ is CHF477.98, compared to a current price of CHF310.35 — trading 35.1% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -8.90%. UnitedHealth Group's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For UnitedHealth Group (XSWX:UNH), the current 3-Year EBITDA Growth Rate is -8.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UnitedHealth Group (XSWX:UNH) Overvalued in 2026?
Based on GuruFocus' analysis, UnitedHealth Group stock appears to be undervalued.
The current stock price of CHF310.35 is trading 35.1% below its estimated GF Value™ of CHF477.98.
Key valuation signals for XSWX:UNH:
3-Year EBITDA Growth Rate: -8.90%
GF Value™: CHF477.98 vs. price of CHF310.35 (35.1% below fair value)
No single metric tells the full story. See the XSWX:UNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
78GF Score
Get the complete analysis for XSWX:UNH
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:UNH has been successfully added to your 
